Enter your terms above and click the 'Search' button.

Showing articles 0 to 14 of 14 Filter Applied: myasthenic syndrome,treatment of (Click to remove) Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases JAMA 291:2367-2375, Dalakas,M.C., 2004 A Randomized Trial of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome Neurol 54:603-607, Sanders,D.B.,et al, 2000 Effects of Intravenous Immunoglobulin on Muscle Weakness & Calcium-Channel Autoantibodies in Lambert-Eaton Myasthenic Synd Neurol 47:678-683, Bain,P.G.,et al, 1996 Clinical and Electrophysiologic Improvement in Lambert-Eaton Syndrome with Intravenous Immunoglobulin Therapy Neurol 42:1422-1423, Bird,S.J., 1992 Response of the Lambert-Eaton Myasthenic Syndrome to Treatment of Associated Small-Cell Lung Carcinoma Neurol 40:1552-1556, Chalk,C.H.,et al, 1990 3, 4-Diaminopyridine in the Treatment of Lambert-Eaton Myasthenic Syndrome NEJM 321:1567-1571, 1607-16081989., McEvoy,K.M.,et al, 1989 Plasma Exchange & Immunosuppressive Drug Treatment in the Lambert-Eaton Myasthenic Syndrome Neurol 34:480-485, Newsom-Davis,J.,et al, 1984 Treatment of Lambert-Eaton Syndrome:3, 4-Diaminopyridine & Pyridostigmine Neurol 34:1324-1330, Lundh,H.,et al, 1984 Plasmapheresis & Immunosuppressive Drug Therapy in the Eaton-Lambert Syndrome Ann Neurol 11:570-575, Da,P.C.,et al, 1982 Treatment with Oral 4-aminopyridine in Disorders of Neuromuscular Transmission Neurol 31:265-271, Murray,N.M.F.,et al, 1981 Eaton-Lambert Myasthenic Syndrome:Long-term Treatment of Three Patients with Prednisone Ann Neurol 10:448-453, Streib,E.W.,et al, 1981 4-Aminopyridine-A New Drug Tested in the Treatment of Eaton-Lambert Syndrome JNNP 40:1109, Lundh,H.,et al, 1977 Important Advances in Clinical Medicine West J Med 123:128, Mosier,J.M.,et al, 1975 The Eaton-Lambert Syndrome in Ocular Myasthenia Gravis Arch Neurol 31:183-186, Oh,S.J., 1974 Showing articles 0 to 14 of 14